FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3524
+0.0172 (5.13%)
At close: Nov 7, 2025, 4:00 PM EST
0.4000
+0.0476 (13.51%)
After-hours: Nov 7, 2025, 7:59 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $18.13 million as of November 7, 2025. Its market cap has decreased by -81.83% in one year.
Market Cap
18.13M
Enterprise Value
20.38M
1-Year Change
-81.83%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $18.13M, a decrease of -98.08%. That is a compound annual growth rate of -89.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 18.13M | -74.16% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |